| abstract |
LIGHT-targeting molecules ( e.g ., LIGHT fusion molecules), anti-HER2 antibody molecules, compositions, e.g ., pharmaceutical compositions thereof, are disclosed. Methods of using these molecules to treat, prevent and/or diagnose hyperproliferative, e.g. , neoplastic, diseases or conditions, including, but not limited to, cancer and metastasis are also provided. |